We have observed
5 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 25, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Composition Comprising The Extracts of Lindera Obtusiloba as Effective Ingredient for Prevention And Treatment of Thrombosis
Photoresist employing photodimerization chemistry and method for manufacturing organic light emitting diode display using the same
OPTICAL WAVEGUIDE, OPTICAL WIRING COMPONENT, OPTICAL WAVEGUIDE MODULE AND ELECTRONIC DEVICE
MELAMINE RESIN DECORATIVE SHEET AND METHOD FOR REPAIRING A FINISHED SURFACE
Liquid crystal horizontal orientation agent, horizontal orientation type liquid crystal composition, and horizontal orientation type liquid crystal display device and method of fabricating the same